63 Saudi and international firms vie to undertake Alkhobar’s corniche project

63 Saudi and international firms vie to undertake Alkhobar’s corniche project
1 / 3
The project is part of the several public-private initiatives currently underway in different parts KSA. (SPA)
63 Saudi and international firms vie to undertake Alkhobar’s corniche project
2 / 3
The project is part of the several public-private initiatives currently underway in different parts KSA. (SPA)
63 Saudi and international firms vie to undertake Alkhobar’s corniche project
3 / 3
The project is part of the several public-private initiatives currently underway in different parts KSA. (SPA)
Short Url
Updated 10 January 2021

63 Saudi and international firms vie to undertake Alkhobar’s corniche project

63 Saudi and international firms vie to undertake Alkhobar’s corniche project
  • The project is part of the several public-private initiatives currently underway in different parts of Saudi Arabia

DAMMAM: The Eastern Province municipality has attracted 63 local, regional and international firms to develop the first project under the “Opportunity, land and loan” initiative at Alkhobar corniche.
A municipality spokesman, Muhammad Al-Sufyan, said the initiative comes in cooperation with the Finance Ministry and the National Center for Privatization at a cost of SR800 million to develop 65,000 sq. meters.
He said the project aims to revitalize and diversify the Kingdom’s economy by promoting tourism, entertainment and other related commercial activities. Al-Sufyan said it will also create job opportunities for young Saudi men and women and improve the quality of life in the Eastern Province and help boost Alkhobar’s chances to become one of the 100 best cities to live in.
The project is part of the several public-private initiatives currently underway in different parts of the Kingdom and in different sectors.
He said the companies involved possess huge experience in developing such projects.
The spokesman said it also shows the importance of Saudi Arabia as a rising hub for future investments.
Al-Sufyan said a special committee has been formed to look into the applications and will select the most capable firm to handle the key development project, which aims to serve the key goals of the Saudi Vision 2030.
 


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 16 January 2021

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.